Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Jun;67(6):1395–1397. doi: 10.1038/bjc.1993.258

High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal.

P Coursaget 1, N Depril 1, M Chabaud 1, R Nandi 1, V Mayelo 1, P LeCann 1, B Yvonnet 1
PMCID: PMC1968506  PMID: 8390289

Abstract

In hepatocellular carcinoma, mutation within the p53 gene occurs mainly at codon 249 and its frequency has been associated with exposure to aflatoxin. As Senegal is a country where liver cancer incidence is one of the highest in the world and where people are highly exposed to aflatoxin, we screened 15 liver cancer samples from this country for mutation at codon 249 of the p53 gene. Non-tumoral DNA from the patients showed a wild type genotype. Mutation at codon 249 of the p53 gene was detected in 10 of the 15 tumour tissues tested (67%). This frequency of mutation in codon 249 of the p53 gene is the highest described. These results confirmed that there is an association between countries of high aflatoxin intake and a high frequency of mutation in codon 249 of p53 gene, and that HBV alone does not contribute to these base changes.

Full text

PDF
1395

Images in this article

1396Figure 1
on p.1396
1396Figure 2
on p.1396

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bressac B., Kew M., Wands J., Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 1991 Apr 4;350(6317):429–431. doi: 10.1038/350429a0. [DOI] [PubMed] [Google Scholar]
  2. Coursaget P., Yvonnet B., Barres J. L., Perrin J., Tortey E., Diop B., Kocheleff P., Duflo B., M'Boup S., Diop-Mar I. Hépatite B et cancer primitif du foie en Afrique Intertropicale. Rev Epidemiol Sante Publique. 1985;33(4-5):267–275. [PubMed] [Google Scholar]
  3. Diop B., Denis F., Barin F., Perrin J., Chiron J. P., Goudeau A., Coursaget P., Maupas P. Epidemiology of primary hepatocellular carcinoma in Senegal. Prog Med Virol. 1981;27:35–40. [PubMed] [Google Scholar]
  4. Dykes D. D. The use of biotinylated DNA probes in parentage testing: non-isotopic labeling and non-toxic extraction. Electrophoresis. 1988 Aug;9(8):359–368. doi: 10.1002/elps.1150090803. [DOI] [PubMed] [Google Scholar]
  5. Fujimoto Y., Hampton L. L., Luo L. D., Wirth P. J., Thorgeirsson S. S. Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates. Cancer Res. 1992 Feb 15;52(4):1044–1046. [PubMed] [Google Scholar]
  6. Harris A. L. Cancer genes. Telling changes of base. Nature. 1991 Apr 4;350(6317):377–378. doi: 10.1038/350377a0. [DOI] [PubMed] [Google Scholar]
  7. Hayward N. K., Walker G. J., Graham W., Cooksley E. Hepatocellular carcinoma mutation. Nature. 1991 Aug 29;352(6338):764–764. doi: 10.1038/352764a0. [DOI] [PubMed] [Google Scholar]
  8. Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 mutations in human cancers. Science. 1991 Jul 5;253(5015):49–53. doi: 10.1126/science.1905840. [DOI] [PubMed] [Google Scholar]
  9. Hosono S., Lee C. S., Chou M. J., Yang C. S., Shih C. H. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines. Oncogene. 1991 Feb;6(2):237–243. [PubMed] [Google Scholar]
  10. Hsu I. C., Metcalf R. A., Sun T., Welsh J. A., Wang N. J., Harris C. C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 1991 Apr 4;350(6317):427–428. doi: 10.1038/350427a0. [DOI] [PubMed] [Google Scholar]
  11. Murakami Y., Hayashi K., Hirohashi S., Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 1991 Oct 15;51(20):5520–5525. [PubMed] [Google Scholar]
  12. Sears L. E., Moran L. S., Kissinger C., Creasey T., Perry-O'Keefe H., Roskey M., Sutherland E., Slatko B. E. CircumVent thermal cycle sequencing and alternative manual and automated DNA sequencing protocols using the highly thermostable VentR (exo-) DNA polymerase. Biotechniques. 1992 Oct;13(4):626–633. [PubMed] [Google Scholar]
  13. Sell S., Hunt J. M., Dunsford H. A., Chisari F. V. Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice. Cancer Res. 1991 Feb 15;51(4):1278–1285. [PubMed] [Google Scholar]
  14. Thiers V., Nakajima E., Kremsdorf D., Mack D., Schellekens H., Driss F., Goudeau A., Wands J., Sninsky J., Tiollais P. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet. 1988 Dec 3;2(8623):1273–1276. doi: 10.1016/s0140-6736(88)92891-7. [DOI] [PubMed] [Google Scholar]
  15. Wild C. P., Jiang Y. Z., Allen S. J., Jansen L. A., Hall A. J., Montesano R. Aflatoxin-albumin adducts in human sera from different regions of the world. Carcinogenesis. 1990 Dec;11(12):2271–2274. doi: 10.1093/carcin/11.12.2271. [DOI] [PubMed] [Google Scholar]
  16. Zagursky R. J., Conway P. S., Kashdan M. A. Use of 33P for Sanger DNA sequencing. Biotechniques. 1991 Jul;11(1):36–38. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES